CRNX — Crinetics Pharmaceuticals, Inc. stock price, charts and financials

QT81Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
84.95
+0.00%
OverviewShort InterestFilings
CRNXQT81Crinetics Pharmaceuticals, Inc.·NASDAQ
84.95+0.00%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 11, 202615-12G15-12G
Sep 01, 2026S-8 POSS-8 POS
Sep 01, 2026S-8 POSS-8 POS
Sep 01, 2026S-8 POSS-8 POS
Sep 01, 2026S-8 POSS-8 POS
Sep 01, 20264Statement of changes in beneficial ownership
Sep 01, 20264Statement of changes in beneficial ownership
Sep 01, 20264Statement of changes in beneficial ownership
Sep 01, 2026S-8 POSS-8 POS
Sep 01, 20264Statement of changes in beneficial ownership
Sep 01, 2026POSASRPOSASR
Sep 01, 20264Statement of changes in beneficial ownership
Sep 01, 20264Statement of changes in beneficial ownership
Sep 01, 20264Statement of changes in beneficial ownership
Sep 01, 2026S-8 POSS-8 POS
Sep 01, 20268-KCurrent report
Sep 01, 20264Statement of changes in beneficial ownership
Sep 01, 2026S-8 POSS-8 POS
Sep 01, 20264Statement of changes in beneficial ownership
Sep 01, 202625-NSENotification of removal from listing
Sep 01, 20264Statement of changes in beneficial ownership
Sep 01, 20264Statement of changes in beneficial ownership
Sep 01, 2026POSASRPOSASR
Sep 01, 2026S-8 POSS-8 POS
Sep 01, 2026S-8 POSS-8 POS
#1 / 25 of 548
Page
▼
/ 22